$MDXG
MIMEDX GROUP, INC.

2015 Q4 Form 10-Q Financial Statement

#000137633915000100 Filed on November 06, 2015

View on sec.gov

Income Statement

Concept 2015 Q4 2015 Q3 2014 Q4
Revenue $51.84M $49.02M $39.57M
YoY Change 30.99% 46.23% 119.92%
Cost Of Revenue $4.990M $4.979M $3.600M
YoY Change 38.61% 48.72% 15.76%
Gross Profit $46.85M $44.04M $35.97M
YoY Change 30.23% 45.96% 141.71%
Gross Profit Margin 90.38% 89.84% 90.9%
Selling, General & Admin $36.52M $34.90M $29.24M
YoY Change 24.9% 44.26% 104.76%
% of Gross Profit 77.95% 79.26% 81.28%
Research & Development $2.340M $2.187M $1.850M
YoY Change 26.49% 8.59% 34.06%
% of Gross Profit 4.99% 4.97% 5.14%
Depreciation & Amortization $780.0K $470.0K $570.0K
YoY Change 36.84% 50.16% 18.75%
% of Gross Profit 1.66% 1.07% 1.58%
Operating Expenses $39.09M $37.09M $31.32M
YoY Change 24.81% 41.52% 96.61%
Operating Profit $7.759M $6.714M $4.653M
YoY Change 66.75% 79.95% -544.41%
Interest Expense -$70.00K -$10.00K -$10.00K
YoY Change 600.0% -209.58% 0.0%
% of Operating Profit -0.9% -0.15% -0.21%
Other Income/Expense, Net -$5.000K
YoY Change -44.44%
Pretax Income $7.680M $6.709M $4.640M
YoY Change 65.52% 80.25% -426.76%
Income Tax -$5.700M $158.0K $810.0K
% Of Pretax Income -74.22% 2.36% 17.46%
Net Earnings $13.38M $6.551M $3.832M
YoY Change 249.11% 77.05% -368.54%
Net Earnings / Revenue 25.81% 13.37% 9.68%
Basic Earnings Per Share $0.13 $0.06 $0.04
Diluted Earnings Per Share $0.11 $0.06 $0.03
COMMON SHARES
Basic Shares Outstanding 109.0M shares 106.5M shares 106.9M shares
Diluted Shares Outstanding 114.6M shares

Balance Sheet

Concept 2015 Q4 2015 Q3 2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $31.50M $47.60M $52.30M
YoY Change -39.77% 0.63% 18.59%
Cash & Equivalents $26.30M $41.07M $46.58M
Short-Term Investments $3.000M $6.500M $5.800M
Other Short-Term Assets $215.0K $2.700M $1.500M
YoY Change -85.67% 35.0% 15.38%
Inventory $7.460M $5.653M $5.133M
Prepaid Expenses $3.394M
Receivables $53.76M $46.78M $26.67M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $96.31M $102.7M $85.68M
YoY Change 12.41% 32.98% 31.03%
LONG-TERM ASSETS
Property, Plant & Equipment $9.475M $8.376M $5.447M
YoY Change 73.95% 65.79% 33.31%
Goodwill $4.040M $4.040M $4.040M
YoY Change 0.0% -0.01% 0.0%
Intangibles $10.76M $10.74M $10.85M
YoY Change -0.76% -2.01% -2.99%
Long-Term Investments $0.00 $0.00 $3.300M
YoY Change -100.0%
Other Assets $15.30M $26.00K $0.00
YoY Change
Total Long-Term Assets $39.60M $23.18M $23.58M
YoY Change 67.94% 15.6% 22.15%
TOTAL ASSETS
Total Short-Term Assets $96.31M $102.7M $85.68M
Total Long-Term Assets $39.60M $23.18M $23.58M
Total Assets $135.9M $125.9M $109.3M
YoY Change 24.4% 29.4% 29.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.633M $7.244M $3.661M
YoY Change 81.18% 162.52% 47.0%
Accrued Expenses $4.644M $4.097M $2.504M
YoY Change 85.46% 105.88% 78.09%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $26.78M $24.35M $18.40M
YoY Change 45.5% 68.53% 91.55%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.148M $1.053M $1.526M
YoY Change -24.77% -34.67% 0.53%
Total Long-Term Liabilities $1.148M $1.053M $1.526M
YoY Change -24.77% -34.67% 0.53%
TOTAL LIABILITIES
Total Short-Term Liabilities $26.78M $24.35M $18.40M
Total Long-Term Liabilities $1.148M $1.053M $1.526M
Total Liabilities $27.93M $25.41M $19.93M
YoY Change 40.12% 58.18% 79.13%
SHAREHOLDERS EQUITY
Retained Earnings -$38.13M -$51.51M -$67.58M
YoY Change -43.58% -27.87% -8.43%
Common Stock $109.0K $109.0K $108.0K
YoY Change 0.93% 1.08% 3.85%
Preferred Stock
YoY Change
Treasury Stock (at cost) $17.13M $4.154M $5.637M
YoY Change 203.8% -22.17% 22448.0%
Treasury Stock Shares 2.106M shares 426.5K shares 986.6K shares
Shareholders Equity $34.72M $100.5M $89.33M
YoY Change
Total Liabilities & Shareholders Equity $135.9M $125.9M $109.3M
YoY Change 24.4% 29.4% 29.0%

Cashflow Statement

Concept 2015 Q4 2015 Q3 2014 Q4
OPERATING ACTIVITIES
Net Income $13.38M $6.551M $3.832M
YoY Change 249.11% 77.05% -368.54%
Depreciation, Depletion And Amortization $780.0K $470.0K $570.0K
YoY Change 36.84% 50.16% 18.75%
Cash From Operating Activities $4.360M $7.310M $8.280M
YoY Change -47.34% -18.32% 897.59%
INVESTING ACTIVITIES
Capital Expenditures -$1.910M -$1.850M -$840.0K
YoY Change 127.38% 110.23% 68.0%
Acquisitions
YoY Change
Other Investing Activities $3.500M $750.0K -$9.000M
YoY Change -138.89%
Cash From Investing Activities $1.590M -$1.100M -$9.840M
YoY Change -116.16% 25.0% 1868.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -18.54M -3.730M 880.0K
YoY Change -2206.82% 6116.67% -97.66%
NET CHANGE
Cash From Operating Activities 4.360M 7.310M 8.280M
Cash From Investing Activities 1.590M -1.100M -9.840M
Cash From Financing Activities -18.54M -3.730M 880.0K
Net Change In Cash -12.59M 2.480M -680.0K
YoY Change 1751.47% -69.04% -101.79%
FREE CASH FLOW
Cash From Operating Activities $4.360M $7.310M $8.280M
Capital Expenditures -$1.910M -$1.850M -$840.0K
Free Cash Flow $6.270M $9.160M $9.120M
YoY Change -31.25% -6.82% 585.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001376339
CY2015Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
108962400 shares
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Document Period End Date
DocumentPeriodEndDate
2015-09-30
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
MIMEDX GROUP, INC.
CY2015Q3 mdxg Capital Leases Interest Rate Effective Percentage Maximum
CapitalLeasesInterestRateEffectivePercentageMaximum
0.12
CY2015Q3 mdxg Capital Leases Interest Rate Effective Percentage Minimum
CapitalLeasesInterestRateEffectivePercentageMinimum
0.03
CY2014Q4 mdxg Intangible Assets Accumulated Amortization And Impairment Charges
IntangibleAssetsAccumulatedAmortizationAndImpairmentCharges
3932000 USD
CY2015Q3 mdxg Intangible Assets Accumulated Amortization And Impairment Charges
IntangibleAssetsAccumulatedAmortizationAndImpairmentCharges
4631000 USD
mdxg Loss Contingency Periodfor Plaintiffto Proceed
LossContingencyPeriodforPlaintifftoProceed
P120D
mdxg Number Of Share Based Compensation Plans
NumberOfShareBasedCompensationPlans
3 plan
mdxg Numberof Patients
NumberofPatients
150 patient
CY2015Q3 mdxg Outstanding Assumed Options
OutstandingAssumedOptions
195000 shares
mdxg Paymentsfor Application Costs Patent
PaymentsforApplicationCostsPatent
477000 USD
mdxg Paymentsfor Application Costs Patent
PaymentsforApplicationCostsPatent
594000 USD
mdxg Treasury Stock Brokerage Commissions
TreasuryStockBrokerageCommissions
66000 USD
mdxg Writeoffof Fixed Assets
WriteoffofFixedAssets
0 USD
mdxg Writeoffof Fixed Assets
WriteoffofFixedAssets
319000 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3661000 USD
CY2015Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
7244000 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
26672000 USD
CY2015Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
46778000 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2504000 USD
CY2015Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4097000 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3499000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1592000 USD
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
3859000 USD
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
1474000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
858000 USD
CY2015Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4427000 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
162433000 USD
CY2015Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
156074000 USD
CY2014Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3021000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8161000 USD
CY2015Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4378000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12564000 USD
CY2014Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
232000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
695000 USD
CY2015Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
234000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
699000 USD
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7057713 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7193672 shares
CY2015Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8044742 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7931984 shares
CY2014Q4 us-gaap Assets
Assets
109259000 USD
CY2015Q3 us-gaap Assets
Assets
125927000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
85677000 USD
CY2015Q3 us-gaap Assets Current
AssetsCurrent
102745000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
44078000 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47252000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46582000 USD
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
41073000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3174000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5509000 USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
108776247 shares
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
109467416 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107789611 shares
CY2015Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
109040869 shares
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
108000 USD
CY2015Q3 us-gaap Common Stock Value
CommonStockValue
109000 USD
CY2015Q3 us-gaap Contractual Obligation
ContractualObligation
7829000 USD
CY2015Q3 us-gaap Contractual Obligation Due After Fifth Year
ContractualObligationDueAfterFifthYear
319000 USD
CY2015Q3 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
817000 USD
CY2015Q3 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
2574000 USD
CY2015Q3 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
2327000 USD
CY2015Q3 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
1792000 USD
CY2014Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
3348000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
9065000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
26000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
312000 USD
CY2015Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
4979000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
15217000 USD
CY2014Q3 us-gaap Depreciation
Depreciation
313000 USD
us-gaap Depreciation
Depreciation
864000 USD
CY2015Q3 us-gaap Depreciation
Depreciation
470000 USD
us-gaap Depreciation
Depreciation
1247000 USD
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0090
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.032
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11523000 USD
CY2015Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12997000 USD
CY2015Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
8325684 USD
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
6058000 USD
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
233000 USD
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
833000 USD
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
833000 USD
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
843000 USD
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
932000 USD
CY2015Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
9732000 USD
CY2014Q4 us-gaap Goodwill
Goodwill
4040000 USD
CY2015Q3 us-gaap Goodwill
Goodwill
4040000 USD
CY2014Q3 us-gaap Gross Profit
GrossProfit
30170000 USD
us-gaap Gross Profit
GrossProfit
69585000 USD
CY2015Q3 us-gaap Gross Profit
GrossProfit
44036000 USD
us-gaap Gross Profit
GrossProfit
120244000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3722000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2409000 USD
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
6709000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
16595000 USD
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22000 USD
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
158000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
527000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
81000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
1506000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
355000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3747000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7212000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
20106000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
584000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
520000 USD
CY2015Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
376000 USD
CY2014Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
527000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1087000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
631000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1201000 USD
CY2014Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
14777000 USD
CY2015Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
15371000 USD
CY2014Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
10845000 USD
CY2015Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
10740000 USD
us-gaap Interest Paid
InterestPaid
38000 USD
us-gaap Interest Paid
InterestPaid
18000 USD
CY2014Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1986000 USD
CY2015Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3112000 USD
CY2014Q4 us-gaap Inventory Gross
InventoryGross
5660000 USD
CY2015Q3 us-gaap Inventory Gross
InventoryGross
6347000 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
5133000 USD
CY2015Q3 us-gaap Inventory Net
InventoryNet
5653000 USD
CY2014Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
255000 USD
CY2015Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
694000 USD
CY2014Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
3419000 USD
CY2015Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
2859000 USD
CY2014Q4 us-gaap Investments
Investments
3250000 USD
CY2015Q3 us-gaap Investments
Investments
0 USD
CY2014Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
282000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
847000 USD
CY2015Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
363000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
956000 USD
us-gaap Lessee Leasing Arrangements Operating Leases Term Of Contract
LesseeLeasingArrangementsOperatingLeasesTermOfContract
P5Y
CY2014Q4 us-gaap Liabilities
Liabilities
19930000 USD
CY2015Q3 us-gaap Liabilities
Liabilities
25405000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
109259000 USD
CY2015Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
125927000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
18404000 USD
CY2015Q3 us-gaap Liabilities Current
LiabilitiesCurrent
24352000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3035000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-17690000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2307000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2270000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8516000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14451000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
3700000 USD
us-gaap Net Income Loss
NetIncomeLoss
2387000 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
6551000 USD
us-gaap Net Income Loss
NetIncomeLoss
16068000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
3731000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
2448000 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
6714000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
16613000 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
0 USD
CY2015Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
26000 USD
CY2014Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
716000 USD
CY2015Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
14000 USD
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1526000 USD
CY2015Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1053000 USD
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-39000 USD
CY2015Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-18000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
26585000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
21002000 USD
us-gaap Payments To Acquire Equipment On Lease
PaymentsToAcquireEquipmentOnLease
89000 USD
us-gaap Payments To Acquire Equipment On Lease
PaymentsToAcquireEquipmentOnLease
87000 USD
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
1830000 USD
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
4176000 USD
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1540000 USD
CY2015Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2741000 USD
us-gaap Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
-5312000 USD
us-gaap Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
-21068000 USD
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
0 USD
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
2500000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1497000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3465000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
869000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8946000 USD
CY2015Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
12803000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5447000 USD
CY2015Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8376000 USD
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2014000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5204000 USD
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2187000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6072000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-67575000 USD
CY2015Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-51507000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
175900 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
75100 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2014Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
33518000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
78650000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.15
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
88305987 USD
CY2015Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
10919348 shares
CY2015Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
14575369 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
52331 shares
CY2015Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
49015000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
135461000 USD
CY2014Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
24193000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
61238000 USD
CY2015Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
34901000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
96860000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
8161000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
12564000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.645
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.581
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.636
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.544
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0196
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0168
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0169
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0151
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
26500000 shares
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
14455019 shares
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.70
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
14400192 USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
16474227 shares
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
14575369 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.43
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.60
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
87979308 USD
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
10919348 shares
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
3.57
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.97
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
1.89
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
6.62
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
9.66
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2015Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
75897265 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y2M12D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y8M12D
CY2015Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
2.70
CY2015Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
3.60
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P6Y8M12D
CY2014Q4 us-gaap Short Term Investments
ShortTermInvestments
5750000 USD
CY2015Q3 us-gaap Treasury Stock Value
TreasuryStockValue
4154000 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
21068000 USD
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
2273953 shares
CY2014Q4 us-gaap Treasury Stock Value
TreasuryStockValue
5637000 USD
CY2015Q3 us-gaap Short Term Investments
ShortTermInvestments
6500000 USD
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
13158 shares
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
16493 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1745727 shares
us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
2834042 shares
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
86000 USD
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
164000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
12564000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3465000 USD
us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
22551000 USD
CY2015Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
30000000 USD
CY2014Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
10000000 USD
CY2015Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
20000000 USD
CY2015Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
30000000 USD
CY2015Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
3415000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
89329000 USD
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
100522000 USD
CY2014Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
986636 shares
CY2015Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
426547 shares
CY2014Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
7057713 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
7193672 shares
CY2015Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
8044742 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
7931984 shares
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
112814658 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
112525016 shares
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114556036 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114110120 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105756945 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105331344 shares
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
106511294 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
106178136 shares
us-gaap Revenue Recognition Sales Of Goods
RevenueRecognitionSalesOfGoods
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue Recognition</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company sells its products through a combination of a direct sales force and independent stocking distributors and representatives in the U.S. and independent distributors in international markets. The Company recognizes revenue when title to the goods transfers to customers, provided there are no material remaining performance obligations required of the Company or any matters of customer acceptance. In cases where the Company utilizes distributors or ships product directly to the end user, it recognizes revenue upon shipment provided all other revenue recognition criteria have been met. A portion of the Company's revenue is generated from inventory maintained at hospitals. For these products, revenue is recognized at the time the product has been used or implanted. The Company records estimated sales returns, discounts and allowances as a reduction of net sales in the same period revenue is recognized.&#160;&#160;</font></div></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.&#160;</font></div></div>

Files In Submission

Name View Source Status
0001376339-15-000100-index-headers.html Edgar Link pending
0001376339-15-000100-index.html Edgar Link pending
0001376339-15-000100.txt Edgar Link pending
0001376339-15-000100-xbrl.zip Edgar Link pending
exhibit311-certificationof.htm Edgar Link pending
exhibit312-certificationof.htm Edgar Link pending
exhibit321-certificationof.htm Edgar Link pending
exhibit322-certificationof.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
mdxg-20150930.xml Edgar Link completed
mdxg-20150930.xsd Edgar Link pending
mdxg-20150930_cal.xml Edgar Link unprocessable
mdxg-20150930_def.xml Edgar Link unprocessable
mdxg-20150930_lab.xml Edgar Link unprocessable
mdxg-20150930_pre.xml Edgar Link unprocessable
mdxg-2015930x10xq.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending